Related Experiment Video
Updated: Jul 20, 2026

08:18
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
Vinegar: medicinal uses and antiglycemic effect.
Carol S Johnston1, Cindy A Gaas
1Department of Nutrition, Arizona State University, Mesa, Arizona, USA.
Medgenmed : Medscape General Medicine
|August 24, 2006
Summary
Vinegar has a long history of medicinal use, with recent studies focusing on its antiglycemic effects. This review explores the scientific evidence for vinegar
Area of Science:
- History of Medicine
- Biochemistry
- Nutritional Science
Background:
- Vinegar boasts a rich historical tapestry, with ancient civilizations utilizing it for preservation, medicine, and even military strategy.
- Traditional medical practices extensively employed vinegar for treating various ailments, predating modern pharmaceutical interventions.
- Historical records indicate the use of vinegar as a folk remedy for managing blood sugar levels in individuals with diabetes.
Purpose of the Study:
- To systematically review the scientific evidence supporting the historical and contemporary medicinal applications of vinegar.
- To specifically investigate and evaluate recent research on vinegar's efficacy as an antiglycemic agent.
Main Methods:
- A comprehensive literature search was conducted using MEDLINE, employing keywords such as 'vinegar, glucose,' 'vinegar, cancer,' and 'vinegar, infection.'
- Inclusion criteria focused on relevant randomized controlled trials and case-control studies to ensure the quality of evidence.
- The review synthesizes findings from epidemiological studies and clinical trials to assess vinegar's medicinal properties.
Main Results:
- Historical accounts provide anecdotal evidence for vinegar's efficacy in wound management, infection prevention, and treating diverse conditions.
- Emerging scientific data suggests a significant role for vinegar in modulating glucose metabolism, supporting its antiglycemic potential.
- Further research is warranted to fully elucidate the mechanisms and clinical benefits of vinegar in various health contexts.
Conclusions:
- Vinegar possesses a long-standing history of medicinal use, supported by both traditional practices and emerging scientific validation.
- Current evidence highlights vinegar's promising antiglycemic properties, offering a potential complementary approach for diabetes management.
- Continued scientific inquiry is essential to explore the full spectrum of vinegar's therapeutic benefits and establish evidence-based applications.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Oral Hypoglycemic Agents: Sulfonylureas
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...